Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201412038 Principal Investigator: Olsen, Jeffrey
Title: Prospective Phase I Study of nab-Paclitaxel plus Gemcitabine with Concurrent MR-Guided IMRT in Patients with Locally Advanced Pancreatic Cancer
Description: The purpose of this research study is to find the highest dose of radiation that can be safely given during chemoradiotherapy with modern chemotherapy agents to treat pancreas cancer. In addition, the machine being used to administer the radiation therapy uses a technique called magnetic resonance i...MORE
___________________________________________________________________________________________________
 Number: 201501143 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 2, Multicenter Study of FOLFIRINOX Followed by Ipilimumab in Combination with Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine in the Treatment of Metastatic Pancreatic Cancer
Description: The purpose of this research study is to compare the effectiveness of ipilimumab and a pancreatic tumor vaccine to continuation of chemotherapy in patients with stable metastatic pancreatic cancer after upfront FOLFIRINOX(5-fluorouracil/irinotecan/oxaliplatin) treatment....MORE
___________________________________________________________________________________________________
 Number: 201504029 Principal Investigator: Wang-Gillam, Andrea
Title: An Open-label Phase 1b Study to Evaluate the Safety and Efficacy of CCX872-B in Patients with Pancreatic Adenocarcinoma
Description: The purpose of this study is to determine how well the investigational drug CCX872-B treats pancreatic cancer and to determine what side effect patients experience while receiving the drug....MORE
___________________________________________________________________________________________________
 Number: 201410173 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients with gBRCA Mutated Metastatic Pancreatic Cancer whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy
Description: The purpose of this research study is to see if a new treatment being tested, called Olaparib, is effective in treating pancreatic cancer and preventing it from coming back as quickly as it could otherwise....MORE
___________________________________________________________________________________________________
 Number: 201404049 Principal Investigator: Tan, Benjamin
Title: A Phase 1/2 Therapeutic, Open Label, Multi-Center Clinical Trial of NPC-1C, a Chimeric Monoclonal Antibody, in Adults with Recurrent, Locally Advanced Unresectable or Metastatic Pancreatic and Colorectal Cancer After Standard Therapy
Description: The purpose of this study is to evaluate the safety and effectiveness of the experimental drug called NPC-1C in patients with metastatic pancractic or colorectal cancer....MORE
___________________________________________________________________________________________________
 Number: 201404048 Principal Investigator: Wang-Gillam, Andrea
Title: A Multicenter Phase II Study of NPC-1C in Combination with Gemcitabine and nab-Paclitaxel versus Gemcitabine and nab-Paclitaxel alone in Patients with Metastatic or Locally Advanced Pancreatic Cancer Previously Treated with FOLFIRINOX
Description: The purpose of this study is to find out if giving NPC-1C (an investigational drug) with standard chemotherapy helps control pancreatic cancer better than standard chemotherapy alone....MORE
___________________________________________________________________________________________________
 Number: 201311061 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 1b/2 Study of OMP-59R5 in Combination with Nab-Paclitaxel and Gemcitabine in Subjects with Previously Untreated Stage IV Pancreatic Cancer
Description: The purpose of this study is to test if OMP-59R5 is able to delay tumor growth, or increase how long people with metastatic pancreatic cancer live, or shrink tumors in subjects with stage IV pancreatic cancer who have not been treated....MORE
___________________________________________________________________________________________________
 Number: 201310160 Principal Investigator: Wang-Gillam, Andrea
Title: An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination with Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects with Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Description: The purpose of this research study is to investigate the safety of the study drug TH-302 in combination with two other chemotherapy drugs in patients with advanced pancreatic cancer who have not been treated before, and to find out the best dose to further test the study drug....MORE
___________________________________________________________________________________________________
 Number: 201304099 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic Cancer
Description: There are two parts to this study. The purpose of both parts is to evaluate PEGPH20 at a dose of 3.0 µg/kg in combination with 2 chemotherapy drugs (a standard dose of gemcitabine plus a dose of nab-paclitaxel that has been tested in pancreatic cancer patients) versus gemcitabine and nab-paclitaxel ...MORE
___________________________________________________________________________________________________
 Number: 201109243 Principal Investigator: Linehan, David
Title: 30-day readmission following pancreatectomy: a root-cause analysis
___________________________________________________________________________________________________
 Number: 201105335 Principal Investigator: Strasberg, Steven
Title: Whipple at the Splenic Artery: A Procedure for Ductal Adenocarcinoma of the Pancreas with Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study
Description: The main purpose of this study is to determine whether the standard surgical procedure used to remove pancreas tumors (called a Whipple procedure) is effective and safe in removing tumors located near or on the major veins that drain the intestine and spleen and supply blood to the liver. The abbrev...MORE
___________________________________________________________________________________________________
 Number: 201103202 Principal Investigator: Wang-Gillam, Andrea
Title: Construction of Pancreatic Cancer Tissue and Stroma Array
___________________________________________________________________________________________________